###begin article-title 0
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LIM only 4 </italic>
LIM only 4 is overexpressed in late stage pancreas cancer
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
LIM-only 4 (LMO4), a member of the LIM-only (LMO) subfamily of LIM domain-containing transcription factors, was initially reported to have an oncogenic role in breast cancer. We hypothesized that LMO4 may be related to pancreatic carcinogenesis as it is in breast carcinogenesis. If so, this could result in a better understanding of tumorigenesis in pancreatic cancer.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
We measured LMO4 mRNA levels in cultured cells, pancreatic bulk tissues and microdissected target cells (normal ductal cells; pancreatic intraepithelial neoplasia-1B [PanIN-1B] cells; PanIN-2 cells; invasive ductal carcinoma [IDC] cells; intraductal papillary-mucinous adenoma [IPMA] cells; IPM borderline [IPMB] cells; and invasive and non-invasive IPM carcinoma [IPMC]) by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR).
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 301 303 301 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 478 480 478 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 516 518 516 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 619 621 619 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 637 639 637 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 664 666 664 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 87 92 <span type="species:ncbi:9606">human</span>
9 of 14 pancreatic cancer cell lines expressed higher levels of LMO4 mRNA than did the human pancreatic ductal epithelial cell line (HPDE). In bulk tissue samples, expression of LMO4 was higher in pancreatic carcinoma than in intraductal papillary-mucinous neoplasm (IPMN) or non-neoplastic pancreas (p < 0.0001 for both). We carried out microdissection-based analyses. IDC cells expressed significantly higher levels of LMO4 than did normal ductal epithelia or PanIN-1B cells (p < 0.001 for both) or PanIN-2 cells (p = 0.014). IPMC cells expressed significantly higher levels of LMO4 than did normal ductal epithelia (p < 0.001), IPMA (p < 0.001) and IPMB cells (p = 0.003).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
Pancreatic carcinomas (both IDC and IPMC) expressed significantly higher levels of LMO4 mRNA than did normal ductal epithelia, PanIN-1B, PanIN-2, IPMA and IPMB. These results suggested that LMO4 is overexpressed at late stages in carcinogenesis of pancreatic cancer.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 636 637 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 731 732 731 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1030 1036 1030 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1216 1224 1216 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
Pancreatic cancer is one of the most aggressive malignant tumors. It is the fifth leading cause of cancer death in Japan [1,2] and has the lowest survival rate of any solid cancer [3]. Because the lack of specific symptoms in patients with pancreatic cancer makes early diagnosis difficult, initial diagnosis typically occurs when the tumor has reached an advanced stage [4]. A better understanding of pancreatic carcinogenesis is urgently needed to facilitate early detection. Pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary-mucinous neoplasm (IPMN) were reported to be precursor lesions of pancreatic cancer [5-8]. Development of invasive ductal adenocarcinoma has been proposed to occur via two pathways [9-11], the PanIN-Invasive ductal carcinoma (IDC) progression pathway and the IPM adenoma (IPMA)-invasive IPM carcinoma (IPMC) pathway, although some specific subtypes of IPMN, such as intestinal-type IPMN, may not progress to invasive carcinoma through the same genetic pathway as PanIN. Longnecker et al [12] reported that PanIN-1 and IPMA showed mild dysplasia (grade 1), PanIN-2 and IPM borderline (IPMB) lesions showed moderate dysplasia (grade 2), and PanIN-3 and IPMC (carcinoma in situ [CIS]) showed severe dysplasia (grade 3).
###end p 11
###begin p 12
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 511 517 511 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4</italic>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 952 954 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1121 1123 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1144 1150 1144 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 1151 1153 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1582 1587 1582 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 1653 1661 1653 1661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1753 1758 1753 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 1783 1785 1783 1785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1833 1838 1833 1838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 1935 1937 1935 1937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2000 2004 2000 2004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP7</italic>
###xml 2111 2116 2111 2116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 2117 2119 2117 2119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2349 2351 2349 2351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 2468 2470 2468 2470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 2757 2762 2757 2762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 920 925 <span type="species:ncbi:9606">human</span>
###xml 1313 1318 <span type="species:ncbi:4932">yeast</span>
###xml 1621 1626 <span type="species:ncbi:9606">human</span>
LIM-only 4 (LMO4) is one of the four members (LMOs 1, 2, 3 and 4) of the LIM-only subfamily of LIM domain proteins. LIM domains are an approximately 55-amino acid, cysteine-rich, zinc-binding motif that mediate protein-protein interactions present in a variety of proteins including LIM homeobox proteins [13]. The nuclear LIM-only proteins (LMOs 1-4) lack a DNA-binding domain but still function as transcriptional regulators by recruiting other protein partners including transcription factors [14,15]. Kenny et al [13] reported the isolation and characterization of LMO4, a novel LIM-only gene that is highly expressed in the T-lymphocyte lineage, cranial neural crest cells, somites, dorsal limb bud mesenchyme, motor neurons and Schwann cell progenitors. As well as its role in development, there are several lines of evidence suggesting that LMO4 may have roles in oncogenesis [16]. LMO4, initially described as a human breast tumor autoantigen [17], was reported to have a role in maintaining proliferation of mammary epithelium and suggested that deregulation of this gene may contribute to breast tumorigenesis [18]. Additionally, Sum et al [19] found that LMO4 interacts with the cofactor CtIP and the tumor suppressor breast cancer 1 (BRCA1), and inhibits the transcriptional activity of BRCA1 in both yeast and mammalian cells by functional assays. They concluded that deregulation of LMO4 in breast epithelium directly contributes to breast neoplasia by altering the rate of cellular proliferation and promoting cell invasion. In 2005, Sum and colleagues reported that LMO4 mRNA was overexpressed in 5 of 10 human breast cancer cell lines; in situ hybridization analysis of 177 primary invasive breast carcinomas revealed overexpression of LMO4 in 56% of the specimens [20]. It has also been reported that expression of LMO4 is up-regulated at the invasive front of oral cancer, suggesting a role in cancer cell invasion [21]. It was recently reported that the bone morphogenic protein (BMP7) gene, which controls cell proliferation and apoptosis of mammary epithelial cells, is a direct target of LMO4 [22]. Both pancreatic cancer and breast cancer are known to have an epithelial origin while pancreatic cancer also reveals papillo-tubular structures that are similar to the histological characteristics of the initial breast cancer [23]. As well, known genetic changes in pancreatic cancer often involve the same genes as those found in breast cancer [24]. Taken together, these findings suggest that LMO4 has critical functions in pancreatic carcinogenesis as well as in normal development. Thus clarification of the role of LMO4 may be useful for diagnosis and/or treatment of pancreatic cancer. However, little is known about the role of LMO4 in pancreatic cancer and carcinogenesis.
###end p 12
###begin p 13
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 407 412 407 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
To determine whether LMO4 is correlated with pancreatic cancer and carcinogenesis, we quantified LMO4 mRNA levels in cultured pancreatic cell lines, bulk tissues and microdissection-based target cells (including normal pancreatic ductal, PanIN-1B and PanIN-2, IDC, IPMA, IPMB and IPMC cells), by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR). Our goal was to characterize LMO4 expression in the early and late stages of pancreatic carcinogenesis to clarify both if and when overexpression of LMO4 occurs.
###end p 13
###begin title 14
Materials and methods
###end title 14
###begin title 15
Cultured cells
###end title 15
###begin p 16
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
Fourteen pancreatic cancer cell lines, AsPC-1, KP-1N, KP-2, KP-3, PANC-1, SUIT-2 (provided by Dr. H. Iguchi, National Shikoku Cancer Center, Matsuyama, Japan), MIA PaCa-2 (Japanese Cancer Resource Bank, Tokyo, Japan), NOR-P1 (established in our laboratory), CAPAN-1, CAPAN-2, CFPAC-1, H48N, HS766T and SW1990 (American Type Culture Collection, Manassas, VA, USA), the HPDE cell line and six primary cultures of fibroblasts derived from pancreatic tumors were studied. Cells were maintained as described previously [25].
###end p 16
###begin title 17
Pancreatic tissues
###end title 17
###begin p 18
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 856 857 843 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 907 915 <span type="species:ncbi:9606">patients</span>
Tissue samples were obtained during surgery at Kyushu University Hospital (Fukuoka, Japan) as described previously [26]. In brief, tissue samples were removed and divided into at least three bulk tissue specimens. The first sample was immediately but temporarily preserved in cold PBS and then embedded in OCT compound (Sakura Findek, Tokyo, Japan), snap-frozen for microdissection within 1 hour after resection, and stored at -80degreesC until use. The second sample was fixed in formalin, embedded in paraffin and cut into 4-mum-thick sections for hematoxylin and eosin (H&E) staining. The third sample was immediately snap-frozen for bulk tissue analysis and stored at -80degreesC until use. Tissues adjacent to the specimens were examined histologically and the diagnosis confirmed by two pathologists, Dr Hiroshi Yamaguchi and Dr Kohei Nakata (Figure 1). Written informed consent was obtained from all patients, and the study was approved by our institution's surveillance committee and conducted according to the Helsinki Declaration.
###end p 18
###begin p 19
###xml 0 116 0 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histologic examination of formalin-fixed, paraffin-embedded (FFPE) samples with hematoxylin and eosin (H&amp;E) staining</bold>
Histologic examination of formalin-fixed, paraffin-embedded (FFPE) samples with hematoxylin and eosin (H&E) staining. The stages of the PanIN-IDC pathway are shown as normal pancreatic ductal epithelia (A), pancreatic intraepithelial neoplasm-1B (PanIN-1B) (B), PanIN-2 (C) and invasive ductal carcinoma (IDC) (D). The stages of the intraductal papillary mucinous adenoma (IPMA)-intraductal papillary mucinous carcinoma (IPMC) pathway are shown as IPM adenoma (E), IPM borderline (F) and IPM carcinoma (G). (Magnifications of A to G are 100x, 100x, 100x, 200x, 100x, 200x, 200x, respectively).
###end p 19
###begin title 20
RNA isolation
###end title 20
###begin p 21
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Total RNA was extracted from cultured cells with a High Pure RNA Isolation Kit (Roche, Mannheim, Germany). Total RNA was extracted from bulk tissues with an RNeasy Mini Kit (Qiagen, Tokyo, Japan) following the manufacturer's protocol. Total RNA was extracted from cells isolated by microdissection with the standard acid guanidinium thiocyanate-phenol-chloroform protocol [27] with or without glycogen (Funakoshi, Tokyo, Japan) [26].
###end p 21
###begin title 22
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
Quantitative assessment of LMO4 level by real-time RT-PCR
###end title 22
###begin p 23
###xml 643 648 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 829 834 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 955 959 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S </italic>
###xml 1074 1079 1011 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 1111 1115 1048 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S </italic>
Quantitative real-time RT-PCR was performed with a QuantiTect SYBR Green RT-PCR Kit (Qiagen, Tokyo, Japan) with a Chromo4trade mark System (Bio-Rad, Hercules, CA, USA). In brief, the reaction mixture was first incubated at 50degreesC for 30 min to allow for reverse transcription. PCR was initiated with one cycle of 95degreesC for 15 min to activate the modified Taq polymerase followed by 40 cycles of 94degreesC for 15 sec, 55degreesC for 20 sec, and 72degreesC for 10 sec, and one cycle of 95degreesC for 0 sec, 65degreesC for 15 sec and +0.1degreesC/sec to 95degreesC for melting analysis. Each sample was run in triplicate. The level of LMO4 mRNA expression was calculated from a standard curve constructed with total RNA from the SUIT-2 pancreatic cancer cell line. The range of threshold cycles was from 20-35 cycles for LMO4 primers (forward, 5'-GGA CCG CTT TCT GCT CTA TG-3'; reverse, 5'-AAG GAT CAT GCC ACT TTT GG-3'), and from 7-35 cycles for 18S rRNA primers (forward 5'-GAT ATG CTC ATG TGG TGT TG-3'; reverse, 5'-AAT CTT CTT CAG TCG CTC CA-3'). Expressions of LMO4 mRNA were normalized to that of 18S rRNA.
###end p 23
###begin title 24
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
Microdissection-based quantitative analysis of LMO4 mRNA
###end title 24
###begin p 25
###xml 542 543 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 546 548 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 679 684 678 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 709 711 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
Frozen tissues were cut into 8-mum-thick sections. IDC cells from 8 lesions, PanIN-2 cells from 3 lesions, PanIN-1B cells from 14 lesions, normal ductal epithelial cells from 13 ducts, IPMA cells from 13 lesions, IPMB cells from 15 lesions, and IPMC cells from 8 lesions, including 3 non-invasive IPMC lesions (CIS) and 5 invasive IPMC lesions, were selectively isolated with a laser microdissection and pressure catapulting system (P.A.L.M. Microlaser Technologies, Bernried, Germany) in accordance with the manufacturer's protocols (Figure 2) [28]. After microdissection, total RNA was extracted from the selected cells and subjected to qRT-PCR for quantitative measurement of LMO4 as described previously [26].
###end p 25
###begin p 26
###xml 0 121 0 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pictures of pancreatic normal ductal epithelia, PanIN-1B, IDC, IPMA, IPMB and IPMC lesions stained with 1% toluidine blue</bold>
Pictures of pancreatic normal ductal epithelia, PanIN-1B, IDC, IPMA, IPMB and IPMC lesions stained with 1% toluidine blue. Lanes 1 to 4 show the process of microdissecting the target cells. Before cutting (lane 1), after cutting (lane 2), rest of region (lane 3) and target cells in capture (lane 4). (The magnifications are shown on the pictures).
###end p 26
###begin title 27
Statistical analysis
###end title 27
###begin p 28
###xml 410 412 410 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Data were analyzed with multiple comparison in ANOVA (analysis of variance) and Bivariate Correlations with Statistics Package for Social Science (SPSS) software (SPSS Inc. Chicago, IL, USA) after Kolmogorov-Smirnov test to assure that each data set is showed a normal distribution. For multiple comparisons by ANOVA, we used the least significant difference (LSD) test and set the statistical significance at p < 0.05. We used Spearman test for bivariate correlations.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
Quantitative analysis of LMO4 expression in 14 pancreatic cancer cell lines, a non-neoplastic ductal epithelial cell line and six primary cultures of pancreatic fibroblasts
###end title 30
###begin p 31
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4</italic>
###xml 598 603 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 692 697 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 794 799 794 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 875 876 875 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 169 192 <span type="species:ncbi:333760">human papillomavirus 16</span>
We investigated LMO4 mRNA expression in 14 pancreatic cancer cell lines, HPDE, a normal pancreatic ductal cell line immortalized by transduction with the E6/E7 genes of human papillomavirus 16 [29,30], and 6 primary cultures of pancreatic fibroblasts derived from resected pancreatic tumors. As shown in Figure 3, 9 of the 14 pancreatic cancer cell lines expressed higher levels of LMO4 than did HPDE. We also found that all 6 primary cultures of pancreatic fibroblasts expressed moderate levels of LMO4. Four pancreatic cancer cell lines, Hs766T, AsPC-1, KP-2 and KP-3, expressed higher levels of LMO4 than did any of the primary cultures of pancreatic fibroblasts. We next examined whether LMO4 expression is related to the origin of these cancer cell lines, but found no correlation between LMO4 expression and site of origin, such as primary or metastatic tumors (Figure 3).
###end p 31
###begin p 32
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 0 158 0 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LMO4 </italic>expressions in pancreatic cancer cell lines, a human pancreatic ductal epithelial (HPDE) cell line and primary fibroblasts derived from pancreatic tumors</bold>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 408 413 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 689 691 689 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 714 719 714 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 750 754 750 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S </italic>
###xml 52 57 <span type="species:ncbi:9606">human</span>
LMO4 expressions in pancreatic cancer cell lines, a human pancreatic ductal epithelial (HPDE) cell line and primary fibroblasts derived from pancreatic tumors. Hs766T, AsPC-1, SUIT-2, CAPAN-1, KP-3, KP-2, CAPAN-2, PANC-1 and MIA PaCa-2 cells expressed significantly higher levels of LMO4 (median, 1.07) than did the HPDE cells (median, 0.46). All 6 cultures of primary fibroblasts express moderate levels of LMO4 (median, 0.70). The difference in LMO4 expression between the metastasis group (Hs766T, AsPC-1, SW1990, NOR-P1, SUIT-2 and CAPAN-1; median = 1.06) and the non-metastasis group (KP-2, KP-3, CAPAN-2, PANC-1, MIA PaCa-2 and H48N; median = 0.76) is not statistically significant (p = 0.75). Expression of LMO4 mRNA was normalized to that of 18S rRNA.
###end p 32
###begin title 33
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
Quantitative analyses of LMO4 expression in bulk pancreatic tissues
###end title 33
###begin p 34
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 87 89 87 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 124 126 124 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 224 226 224 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 393 398 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 545 550 545 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 649 651 649 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 724 726 724 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 908 910 908 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 970 975 970 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
In the bulk tissue analyses, we measured LMO4 expression in pancreatic cancer tissues (n = 11), and non-neoplastic tissues (n = 20), normal pancreatic or chronic pancreatitis-related tissues, and non-malignant IPMN tissues (n = 11). As shown in Figure 4, LMO4 expression was highest in the pancreatic cancer tissues with a mean of 0.24 (95% confidence interval [CI], 0.16 - 0.32), whereas the LMO4 expression levels were 0.03 (95% CI, 0.02 - 0.04) in non-neoplastic tissues and 0.08 (95% CI, 0.04 - 0.12) in non-malignant IPMN tissues. The mean LMO4 mRNA level in pancreatic cancer tissues was eight-fold higher than that in non-neoplastic tissues (p < 0.0001) and three-fold higher than that in non-malignant IPMN tissues (p < 0.0001). The mean LMO4 mRNA level in non-malignant IPMN tissues was 2.7-fold higher than that in non-neoplastic tissues, although the difference was not statistically significant (p = 0.053). All data from bulk tissue analyses indicated that LMO4 was overexpressed in pancreatic cancer.
###end p 34
###begin p 35
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 0 144 0 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LMO4 </italic>expressions in bulk pancreatic tissues, including 20 non-neoplastic tissues, 11 non-malignant IPMN tissues and 11 pancreatic cancer tissues</bold>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 513 515 513 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 817 822 817 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 853 857 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S </italic>
LMO4 expressions in bulk pancreatic tissues, including 20 non-neoplastic tissues, 11 non-malignant IPMN tissues and 11 pancreatic cancer tissues. The mean LMO4 expression value for pancreatic cancer samples is 0.24 (95% CI; 0.16 - 0.32), which is higher than the LMO4 level of non-malignant IPMN (mean, 0.08; 95% CI, 0.04 - 0.12) or non-neoplastic tissues (mean, 0.03; 95% CI, 0.02 - 0.04). The difference in LMO4 expression between non-malignant IPMN and non-neoplastic tissues is not statistically significant (p = 0.053). The bottom and the top edges of the box mark the lower bound and upper bound of the 95% Confidence Interval for the Mean, respectively. The center horizontal line is drawn at the sample mean. The center vertical lines drawn from the boxes extend to the minimum and the maximum. Expression of LMO4 mRNA was normalized to that of 18S rRNA.
###end p 35
###begin title 36
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
Microdissection-based quantitative analysis of LMO4 expression in IDC, PanIN-2, PanIN-1B and normal ductal cells
###end title 36
###begin p 37
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
In general, bulk pancreatic tissues are composed of a various types of cells, including ductal epithelial, acinar, islet and mesenchymal cells, and fibroblasts. Cancer cells comprise only 30% - 70% of the cells in bulk tissue specimens of pancreatic cancer [27]. Premalignant cells, such as PanINs, and normal ductal cells comprise even smaller percentages of the cells in non-malignant tissues. The results of our present analyses of cultured cells suggested that LMO4 was expressed in pancreatic fibroblasts (Figure 3). Therefore, to avoid the influence of contaminating non-ductal cells, we used a laser-microdissection (LMD) method to select specific ductal cells for further analysis.
###end p 37
###begin p 38
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 407 409 407 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 446 448 446 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 467 472 467 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 708 713 708 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 829 831 829 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 842 844 842 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 893 898 893 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
To investigate the involvement of LMO4 in the PanIN-IDC pathway, we isolated IDC cells from 8 lesions, PanIN-2 cells from 3 lesions, PanIN-1B cells from 14 lesions and normal ductal epithelial cells from 13 ducts by LMD (Figure 2) for quantitative analysis of LMO4 by RT-PCR. As shown in Figure 5, IDC cells expressed significantly higher levels of LMO4 than did normal ductal epithelial or PanIN-1B cells (p < 0.0001 for both) or PanIN-2 cells (p = 0.014). The mean LMO4 expression level was 2.19 (95% CI, 1.43 - 2.94) in IDC cells, 0.32 (95% CI, 0.18 - 0.45) in PanIN-2 cells, 0.41 (95% CI, 0.27 - 0.54) in PanIN-1B cells and 0.45 (95% CI, 0.30 - 0.60) in normal ductal epithelial cells. The difference in LMO4 expression between PanIN-2 and normal ductal cells or between PanIN-1B and normal ductal cells was not significant (p = 0.54 and p = 0.56, respectively). These data suggested that LMO4 is overexpressed in pancreatic cancer, especially in the invasive step of cancer, but not in the early stage of pancreatic carcinogenesis.
###end p 38
###begin p 39
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 0 145 0 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LMO4 </italic>expressions in the PanIN-IDC pathway, including 13 normal ductal epithelial ducts, 14 PanIN-1B lesions, 3 PanIN-2 lesions, and 8 IDC lesions</bold>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 529 531 529 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 542 544 542 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 845 850 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 881 885 881 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S </italic>
LMO4 expressions in the PanIN-IDC pathway, including 13 normal ductal epithelial ducts, 14 PanIN-1B lesions, 3 PanIN-2 lesions, and 8 IDC lesions. IDC cells (mean, 2.19; 95% CI, 1.43 - 2.94) expressed significantly higher levels of LMO4 than did normal ductal epithelia (mean, 0.45; 95% CI, 0.30 - 0.60), PanIN-1B (mean, 0.41; 95% CI, 0.27 - 0.54), or PanIN-2 cells (mean, 0.32; 95%CI 0.18 - 0.45). The differences in LMO4 expression among PanIN-2, PanIN-1B, and normal ductal epithelial cells are not statistically significant (p = 0.54 and p = 0.56). The bottom and the top edges of the box mark the lower bound and upper bound of the 95% Confidence Interval for the Mean, respectively. The center horizontal line is drawn at the sample mean. The center vertical lines drawn from the boxes extend to the minimum and the maximum. Expression of LMO4 mRNA was normalized to that of 18S rRNA.
###end p 39
###begin title 40
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
Quantitative analyses of LMO4 expressions in IPMC, IPMB, IPMA and normal ductal cells
###end title 40
###begin p 41
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 470 472 470 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 494 496 494 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 521 523 521 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 572 577 572 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 657 662 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 843 848 843 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 923 928 923 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
To investigate the correlation of LMO4 expression with the IPMA-IPMC pathway, we microdissected IPMC cells from 5 invasive lesions and 3 non-invasive lesions (CIS), IPMB cells from 15 lesions, IPMA cells from 13 lesions and normal ductal epithelial cells from 6 ducts. We then measured LMO4 expression in these cells by qRT-PCR (Figure 2). As shown in Figure 6, IPMC cells expressed higher levels of LMO4 (mean, 1.79; 95% CI, 0.99 - 2.58), than did normal ductal cells (p < 0.001), IPMA cells (p < 0.001) and IPMB cells (p = 0.003). There was no significant difference in LMO4 expression between invasive IPMC and non-invasive IPMC (CIS). Although the mean LMO4 expression in IPMB cells (0.98; 95% CI, 0.69 - 1.27) was higher than that in IPMA (0.60; 95% CI, 0.47 - 0.73) or normal ductal cells (0.65; 95% CI, 0.34 - 0.95), the differences in LMO4 expression were not significant. Taken together, these data suggested that LMO4 expression may be up-regulated during the late stages of carcinogenesis of IPMN.
###end p 41
###begin p 42
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 0 189 0 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LMO4 </italic>expressions in the IPMA-IPMC pathway, including 6 normal ductal epithelial ducts, 13 IPMA lesions, 15 IPMB lesions and 8 IPMC lesions (5 for invasive IPMC and 5 for non-invasive IPMCs)</bold>
###xml 243 248 243 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 331 333 331 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 383 385 383 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 464 466 464 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 540 542 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 592 594 592 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 646 648 646 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 968 973 968 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 1004 1008 1004 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S </italic>
LMO4 expressions in the IPMA-IPMC pathway, including 6 normal ductal epithelial ducts, 13 IPMA lesions, 15 IPMB lesions and 8 IPMC lesions (5 for invasive IPMC and 5 for non-invasive IPMCs). IPMC cells expressed significantly higher levels of LMO4 (mean, 1.79; 95% CI, 0.99 - 2.58) than did IPMB (mean, 0.98; 95% CI, 0.69 - 1.27) (p = 0.003), IPMA (mean, 0.60; 95% CI, 0.47 - 0.73) (p < 0.001), or normal ductal epithelial cells (mean, 0.65; 95% CI, 0.34 - 0.95) (p < 0.001). The differences in LMO4 expression between IPMB and IPMA cells (p = 0.09), IPMB and normal ductal epithelial cells (p = 0.2) and IPMA and normal ductal epithelial cells (p = 0.9) are not significant. The bottom and the top edges of the box mark the lower bound and upper bound of the 95% Confidence Interval for the Mean, respectively. The center horizontal line is drawn at the sample mean. The center vertical lines drawn from the boxes extend to the minimum and the maximum. Expression of LMO4 mRNA was normalized to that of 18S rRNA.
###end p 42
###begin title 43
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
Quantitative analyses of LKB1 expressions in cultured and microdissected cells, and correlation analyses between LKB1 and LMO4 in pancreatic carcinogenesis
###end title 43
###begin p 44
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 593 595 593 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a</xref>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 759 761 759 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a</xref>
###xml 879 884 879 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 939 941 939 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 956 958 956 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 1041 1046 1041 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 1050 1055 1050 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 1164 1166 1164 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
###xml 1246 1248 1246 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1263 1265 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
LKB1 (also called STK11) is a tumor suppressor gene in Peutz-Jeghers syndrome [31]. Loss of this gene is found in pancreatic cancer [32,33]. Recently, LKB1 was reported to induce p21 expression in collaboration with LMO4 [34]. To investigate the potential role of LMO4 in pancreatic carcinogenesis, we measured LKB1 mRNA expression in cultured and microdissected cells and investigated any correlation between LKB1 and LMO4 expression. In the analysis of cultured cells, we found significant correlation between LKB1 and LMO4 mRNA levels in primary cultured fibroblasts (n = 6, spearman test, p = 0.024; Figure 7a, top). By contrast, there was no significant correlation between LKB1 and LMO4 mRNA levels in cultured cancer cell lines (n = 14, spearman test, p = 0.33; Figure 7a bottom). In the analysis of microdissected cells, IDC cells expressed significantly lower levels of LKB1 mRNA than did PanIN-1B or normal ductal cells (n = 12, p = 0.02; n = 8; p = 0.002, respectively; Figure 7b top). There was a significant correlation between LKB1 and LMO4 mRNA levels in non-malignant cells, including normal pancreatic ductal epithelia and PanIN-1B cells (n = 20, p = 0.042, Figure 7b middle), but no significant correlation in IDC cells (n = 8, p = 0.45, Figure 7b bottom).
###end p 44
###begin p 45
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Correlation analyses between <italic>LKB1 </italic>and <italic>LMO4 </italic>in pancreatic carcinogenesis</bold>
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 158 160 158 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 207 212 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 258 260 258 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 678 683 678 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 687 692 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 786 788 786 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 830 835 830 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 839 844 839 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 885 887 885 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 919 924 919 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 955 959 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S </italic>
Correlation analyses between LKB1 and LMO4 in pancreatic carcinogenesis. a, Correlation between LKB1 and LMO4 in primary cultured fibroblasts (spearman test, p = 0.037, top) and correlation between LKB1 and LMO4 in cultured cancer cell lines (spearman test, p = 0.39, bottom). b, Expression of LKB1 mRNA levels in microdissected normal ducts, PanIN-1B cells, and IDC cells (top). The bottom and the top edges of the box mark the lower bound and upper bound of the 95% Confidence Interval for the Mean, respectively. The center horizontal line is drawn at the sample mean. The center vertical lines drawn from the boxes extend to the minimum and the maximum. Correlation between LKB1 and LMO4 mRNA levels in non-malignant cells (including normal ducts and PanIN-1B cells, spearman test, p = 0.042, middle), and correlation between LKB1 and LMO4 mRNA levels in IDC cells (spearman test, p = 0.453, bottom). Expression of LMO4 mRNA was normalized to that of 18S rRNA.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 674 678 674 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4</italic>
###xml 840 845 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 1154 1159 1154 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 1400 1405 1400 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 1509 1514 1509 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 1662 1667 1662 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
In the present study, we performed quantitative real-time RT-PCR to measure LMO4 expression during pancreatic carcinogenesis through the PanIN-IDC and IPMA-IPMC pathways. Analyses of cultured cells revealed that 9 of 14 pancreatic cancer cell lines and all primary cultures of pancreatic fibroblasts expressed higher levels of LMO4 than did a non-neoplastic pancreatic ductal cell line. Bulk tissue analysis showed that pancreatic cancer tissues expressed higher levels of LMO4 than non-neoplastic and non-malignant IPMN tissues; however, the difference in LMO4 expression between non-neoplastic tissues and non-malignant IPMN was not significant. To avoid the influence of LMO4-expressing non-ductal cells contained in bulk tissues, we microdissected target cells, such as IDCs, PanINs, IPMNs and non-neoplastic ductal cells, and measured LMO4 expression in the microdissected cells. It is usually difficult to obtain frozen sections of intermediate or high-grade PanIN-2 or PanIN-3 (CIS) or non-invasive IPMC (CIS) lesions. In the present study, we obtained frozen sections from 3 cases of PanIN-2 lesions and 3 of non-invasive IPMC. We found that the LMO4 expression in IDC cells was significantly higher than those in PanIN-1B, PanIN-2, and normal ductal cells; however, the PanIN-2 sample number was small. We also found that both invasive and non-invasive IPMC cells expressed higher levels of LMO4 than did non-malignant IPMN or normal ductal cells. By contrast, we could not detect any differences in LMO4 expression among PanIN-1B, PanIN-2 and normal ductal cells, or among IPMA, IPMB, and normal ductal cells. Taken together, these data suggested that LMO4 expression is up-regulated in pancreatic cancer but not in low-grade intraductal precursors in both the PanIN-IDC and IPMA-IPMC pathways.
###end p 47
###begin p 48
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 410 416 410 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 649 654 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 658 663 658 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 792 797 792 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 801 806 801 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 859 864 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LKB1 </italic>
###xml 1465 1467 1465 1467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1533 1535 1533 1535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 334 339 <span type="species:ncbi:9606">human</span>
This is the first report to use qRT-PCR for analyses of LMO4 expression during pancreatic carcinogenesis. LMO4 is reported to have an oncogenic role in carcinogenesis and in carcinoma progression in breast cancer and SCC [18-21]. However, the human LMO4 gene is located on chromosome 1p22.3 [35], which is a region deleted in several human cancers, such as those of liver, skin, and lung [36,37], and Setogawa et al reported that the tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, suggesting that LMO4 may have a tumor suppressor function [34]. In the present study, we found that there was significant correlation between LMO4 and LKB1 in both primary cultured fibroblasts and microdissected non-malignant cells, but there was not a significant correlation between LMO4 and LKB1 in cancer cells. We also found the downregulation of LKB1 mRNA in IDC cells, consistent with LKB1's tumor suppressive function. Our data suggest that alteration of the LKB1-LMO4 balance is involved in pancreatic carcinogenesis, although the exact function of LMO4 in pancreatic carcinogenesis remains unknown. Taken together, there appears to be a conflicting function of LMO4 in carcinogenesis as a tumor suppressor or as an oncogene; it is reasonable that LMO4, a transcription regulator, may have multiple functions in individual cancers, like E2F1, an another transcription factor, that was reported both as an oncogene by stimulating cell proliferation [38] and as a tumor suppressor by signaling p53-dependent apoptosis [39].
###end p 48
###begin p 49
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 587 595 <span type="species:ncbi:9606">Patients</span>
###xml 848 856 <span type="species:ncbi:9606">patients</span>
Recently, Murphy et al [40] used immunohistochemical staining and reported that a subset of patients with low LMO4 expression-pancreatic cancers had poor outcomes. In the present study, LMO4 mRNA was not overexpressed in any of the 14 pancreatic cancer cell lines. However, all IDC cells microdissected from cancer tissues showed relatively high expression of LMO4 mRNA although the sample number was small. This might have been the result of using of frozen sections with a histological diagnosis of moderately or well-differentiated adenocarcinoma, which can be microdissected easily. Patients with well-differentiated adenocarcinoma usually have better prognosis [41]; thus the present data may be partially consistent with Murphy's result demonstrating that high LMO4-pancreatic cancers are associated with a significant survival advantage for patients with surgical resection.
###end p 49
###begin p 50
Taken together, it remains unclear if LMO4 has an oncogenic function or a tumor suppressive function in pancreatic carcinogenesis. To better clarify the functional roles of LMO4 in pancreatic carcinogenesis, further examinations such as inhibition experiments using RNAi technology are needed.
###end p 50
###begin p 51
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LMO4 </italic>
In conclusion, the present results showed that LMO4 is overexpressed in pancreatic cancer related to both the PanIN-conventional IDC pathway and the IPMA-IPMC pathway, but not at the early stages of pancreatic carcinogenesis.
###end p 51
###begin title 52
Competing interests
###end title 52
###begin p 53
The authors declare that they have no competing interests.
###end p 53
###begin title 54
Authors' contributions
###end title 54
###begin p 55
JY participated in the design of the study, carried out the RNA expression analysis, Laser Capture Microdissection studies, statistical analysis, and drafted the manuscript. KO and KM participated in the design and coordination of the study, performed the statistical analysis, and critically revised the manuscript. LC performed realtime expression analysis and critically revised the manuscript. KN and HY participated in histologic examination and critically revise the manuscript. HF, TE and HK performed the statistical analysis and critically revised the manuscript. MT planned and coordinated the study, and critically revised the manuscript. All authors have read and approved the final version of the manuscript.
###end p 55
###begin title 56
Acknowledgements
###end title 56
###begin p 57
We thank Miyuki Ohmori for expert technical assistance in preparing frozen sections for microdissection, and thank Shoko Sadatomi, Midori Sato, and Emiko Manabe for help in maintaining the cultures of cell lines and clinical samples. This work has been supported by the grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Fukuoka Cancer Society, Pancreas Research Foundation of Japan; Clinical Research Foundation; and Kaibara Morikazu Medical Science Promotion Foundation. We appreciate for the technical supports from the Research Support Center, Graduate School of Medical Sciences, Kyushu University, Japan.
###end p 57
###begin article-title 58
Pancreatic carcinoma
###end article-title 58
###begin article-title 59
Japan Pancreatic Cancer Registry: current status
###end article-title 59
###begin article-title 60
Pancreatic Cancer Registry in Japan: 20 years of experience
###end article-title 60
###begin article-title 61
Important clues to the diagnosis of pancreatic cancer
###end article-title 61
###begin article-title 62
Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas
###end article-title 62
###begin article-title 63
An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms
###end article-title 63
###begin article-title 64
K-ras mutations in pancreatic ductal proliferative lesions
###end article-title 64
###begin article-title 65
Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas
###end article-title 65
###begin article-title 66
###xml 111 119 <span type="species:ncbi:9606">patients</span>
Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients
###end article-title 66
###begin article-title 67
Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions
###end article-title 67
###begin article-title 68
Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors
###end article-title 68
###begin article-title 69
Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement
###end article-title 69
###begin article-title 70
Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis
###end article-title 70
###begin article-title 71
###xml 118 123 <span type="species:ncbi:9606">human</span>
The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13
###end article-title 71
###begin article-title 72
TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11)
###end article-title 72
###begin article-title 73
LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells
###end article-title 73
###begin article-title 74
###xml 34 39 <span type="species:ncbi:9606">human</span>
Molecular cloning of LMO41, a new human LIM domain gene
###end article-title 74
###begin article-title 75
The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer
###end article-title 75
###begin article-title 76
The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity
###end article-title 76
###begin article-title 77
Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer
###end article-title 77
###begin article-title 78
The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity
###end article-title 78
###begin article-title 79
The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells
###end article-title 79
###begin article-title 80
Obstructive jaundice in a metastatic tumor of the pancreas from breast cancer: a case report
###end article-title 80
###begin article-title 81
DPC4 gene in various tumor types
###end article-title 81
###begin article-title 82
Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions
###end article-title 82
###begin article-title 83
Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer
###end article-title 83
###begin article-title 84
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
###end article-title 84
###begin article-title 85
A new molecular biology approach in morphology: basic method and application of laser microdissection
###end article-title 85
###begin article-title 86
###xml 81 86 <span type="species:ncbi:9606">human</span>
Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma
###end article-title 86
###begin article-title 87
###xml 9 14 <span type="species:ncbi:9606">human</span>
Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype
###end article-title 87
###begin article-title 88
Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase
###end article-title 88
###begin article-title 89
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas
###end article-title 89
###begin article-title 90
Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers
###end article-title 90
###begin article-title 91
The tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and Ldb1
###end article-title 91
###begin article-title 92
Characterization of the Lmo4 gene encoding a LIM-only protein: genomic organization and comparative chromosomal mapping
###end article-title 92
###begin article-title 93
Correlation of Allelic Losses and Clinicopathological Factors in Primary Breast Cancers
###end article-title 93
###begin article-title 94
###xml 37 42 <span type="species:ncbi:9606">human</span>
Allelic imbalance on chromosome 1 in human breast cancer. II. Microsatellite repeat analysis
###end article-title 94
###begin article-title 95
###xml 27 30 <span type="species:ncbi:10116">rat</span>
Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation
###end article-title 95
###begin article-title 96
Gene expression profiling of E2F-1-induced apoptosis
###end article-title 96
###begin article-title 97
Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma
###end article-title 97
###begin article-title 98
Long-term survival and prognostic indicators in small (< or = 2 cm) pancreatic cancer
###end article-title 98

